US Therapeutic Plasma Exchange Market Report 2020 with Feasibility Study of Future Projects

The US therapeutic plasma exchange market is expanding rapidly, propelled by increasing prevalence of autoimmune diseases and neurological disorders. With advancements in technology and expanded clinical applications, this therapy offers personalized treatment options and improved patient

The US Therapeutic Plasma Exchange Market is projected to reach USD 243 million by 2025, at a CAGR of 6.3% during the forecast period. Growth in this market is driven by the rising prevalence of chronic diseases and technological advancements. However, factors such as the high cost of apheresis devices and therapeutic plasma exchange procedures and installation of apheresis devices through a rental model are expected to restrain the growth of this market to a certain extent during the forecast period.

Key players in the US therapeutic plasma exchange market:

The prominent players in the US therapeutic plasma exchange market Terumo BCT, Inc. (US), Fresenius SE Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), Nikkiso Co., Ltd. (Japan), Miltenyi Biotec (Germany), Medica S.p.A. (Italy), Medicap Clinic GmbH (Germany), and Infomed (Switzerland).

Download a FREE Sample PDF of the US Therapeutic Plasma Exchange Market Research Report at https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=87153046utm_source=Ganeshutm_medium=P

Scope of the Report:

The research report categorizes the market into the following segments and subsegments: 

US Therapeutic Plasma Exchange Market, By Product Technology

  • By Product
    • Consumables
    • Devices
  • By Technology
    • Centrifugation
    • Membrane Separation

US Therapeutic Plasma Exchange Market, By Indication

  • Neurological Disorders
    • Guillain–Barré syndrome
    • Chronic inflammatory demyelinating polyneuropathy
    • Myasthenia gravis
    • Multiple sclerosis
    • PANDASa 
  • Hematology Disorders
    • Thrombotic thrombocytopenic purpura
    • Atypical haemolytic uraemic syndrome
    • Hyperviscosity syndromes
    • Severe/symptomatic Cryoglobulinemia
  • Renal Disorders
    • Goodpasture’s syndrome
    • Wegener’s glomerulonephritis
    • Antibody-mediated renal transplant rejection
  • Metabolic Disorders
    • Familial hypercholesterolaemia (homozygous)
  • Other Indications 

US Therapeutic Plasma Exchange Market, By End User

  • Blood Collection Centres Blood Component Providers
  • Hospitals Transfusion Centres
  • Other End Users 

Consumables segment to witness the highest growth during the forecast period

Based on products, the US therapeutic plasma exchange market has been segmented into devices and consumables. The consumables segment witness the highest growth during the forecast period. The fastest growth of this segment can be attributed to the recurrent use of these products, the increasing number of therapeutic plasma exchange procedures, and favorable reimbursement policies for TPE procedures.

The centrifugation segment is expected to account for the largest share of the US therapeutic plasma exchange market in 2019

On the basis of technology, the US therapeutic plasma exchange market has been segmented into centrifugation and membrane separation. In 2019, the centrifugation technology segment accounted for the largest share of the US therapeutic plasma exchange market. The large share of this segment can be attributed to the advantages offered by centrifugation over membrane separation, such as high efficiency and its ability to separate all types of blood components.

Neurological segment to witness the highest growth during the forecast period

On the basis of indication, the US therapeutic plasma exchange market has been segmented into neurological disorders, renal disorders, hematologic disorders, metabolic disorders, and other indications.

In 2019, the neurological disorders segment accounted for the largest share of the US therapeutic plasma exchange market.  Growth in this market is majorly driven by the rising prevalence and incidence of neurological diseases in the geriatric population, increasing awareness about the treatment of neurological diseases using plasma exchange, and rising investments by key players for RD on the new application areas of therapeutic plasma exchange in the treatment of neurological disorders.

Direct Purchase of the US Therapeutic Plasma Exchange Market Research Report at https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=87153046utm_source=Ganeshutm_medium=P

The blood collection centers and blood component providers segment is expected to account for the largest share of the US therapeutic plasma exchange market in 2019

On the basis of end users, the US therapeutic plasma exchange market has been segmented into blood

collection centers and blood component providers, hospitals and transfusion centers, and other end users. In 2019, the blood collection centers and blood component providers segment accounted for the largest share of the US therapeutic plasma exchange market. The large share of this end-user segment is mainly attributed to the rising number of blood component donations, the growing number of blood centers, and the increasing number of therapeutic plasma exchange procedures and plasma donations due to COVID-19.


Juan Martinez

15 Blog posts

Comments